CA2087883C - Utilisation de beta-alethine en culture cellulaire et en therapie - Google Patents

Utilisation de beta-alethine en culture cellulaire et en therapie Download PDF

Info

Publication number
CA2087883C
CA2087883C CA 2087883 CA2087883A CA2087883C CA 2087883 C CA2087883 C CA 2087883C CA 2087883 CA2087883 CA 2087883 CA 2087883 A CA2087883 A CA 2087883A CA 2087883 C CA2087883 C CA 2087883C
Authority
CA
Canada
Prior art keywords
alethine
cell
beta
cells
physiologically compatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 2087883
Other languages
English (en)
Other versions
CA2087883A1 (fr
Inventor
Galen D. Knight
Paul L. Mann
Terence J. Scallen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002481077A priority Critical patent/CA2481077A1/fr
Publication of CA2087883A1 publication Critical patent/CA2087883A1/fr
Application granted granted Critical
Publication of CA2087883C publication Critical patent/CA2087883C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2087883 1992-07-27 1993-01-22 Utilisation de beta-alethine en culture cellulaire et en therapie Expired - Lifetime CA2087883C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002481077A CA2481077A1 (fr) 1992-07-27 1993-01-22 Utilisation de beta-alethine en culture cellulaire et en therapie

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US91925392A 1992-07-27 1992-07-27
US07/919,253 1992-07-27
US92497792A 1992-08-05 1992-08-05
US07/924,977 1992-08-05

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002481077A Division CA2481077A1 (fr) 1992-07-27 1993-01-22 Utilisation de beta-alethine en culture cellulaire et en therapie

Publications (2)

Publication Number Publication Date
CA2087883A1 CA2087883A1 (fr) 1994-01-28
CA2087883C true CA2087883C (fr) 2010-09-14

Family

ID=27129768

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2087883 Expired - Lifetime CA2087883C (fr) 1992-07-27 1993-01-22 Utilisation de beta-alethine en culture cellulaire et en therapie

Country Status (1)

Country Link
CA (1) CA2087883C (fr)

Also Published As

Publication number Publication date
CA2087883A1 (fr) 1994-01-28

Similar Documents

Publication Publication Date Title
Murakami et al. Hormonal control of human colon carcinoma cell growth in serum-free medium.
PRASAD Morphological differentiation induced by prostaglandin in mouse neuroblastoma cells in culture
Nakabayashi et al. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium
Gibson et al. Synthesis of a low molecular weight collagen by chondrocytes from the presumptive calcification region of the embryonic chick sterna: the influence of culture with collagen gels.
CS215108B2 (en) Method of making the interferrone
CN105524882B (zh) 用于免疫杀伤细胞体外扩增的血清替代物组合
EP0538330B1 (fr) Utilisation de beta-alethine pour des cultures cellulaires et a des fins therapeutiques
Moser Modern approaches to the study of mammalian cells in culture
US6245561B1 (en) β-alethine use in cell culture and therapy
CA2087883C (fr) Utilisation de beta-alethine en culture cellulaire et en therapie
Imamura et al. Serum requirement for in vitro invasion by tumor cells
CN107502592A (zh) 一种免疫细胞无血清培养基及其制备方法
US5318906A (en) Agent for stimulating growth of animal cells and serum-free medium containing same
US6046241A (en) β-alethine as anti-tumor agent
US5370868A (en) Therapeutic use of vitaletheine modulators in neoplasia
CA2481077A1 (fr) Utilisation de beta-alethine en culture cellulaire et en therapie
CN113817677B (zh) 泛酸或其衍生物与α-D-葡萄糖-1,6-二磷酸或其衍生物在促进DC迁移中的用途
Pellett et al. Renal cell culture using autopsy material from children with cystinosis
Knight et al. Seemingly diverse activities of β-alethine
CN106540247B (zh) 肿瘤通用型成纤维细胞疫苗及其制备方法和用途
EP0539525B1 (fr) Vitaletheine et son utilisation dans la culture cellulaire et la therapie
CN111996166B (zh) 一种负载的dc细胞、dc-cik细胞及在肿瘤细胞治疗方面的应用
Harris Essential growth factor in serum dialysate for chick skeletal muscle fibroblasts.
US20030166715A1 (en) Use of vitaletheine modulators in the prophylaxis and treatment of disease
CN116024170A (zh) Nkt细胞培养基及培养方法

Legal Events

Date Code Title Description
EEER Examination request
FZDC Correction of dead application (reinstatement)
MKEX Expiry

Effective date: 20130122